ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

31.52
Delayed Data
As of Feb 23
 +1.28 / +4.23%
Today’s Change
25.06
Today|||52-Week Range
41.20
+4.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line-78.7M-87.8M-67.4M-65.2M
 
 
 
 
 
Depreciation630.0K639.0K676.0K697.0K
 
 
 
 
 
Total Other Cash Flow14.8M15.5M18.1M19.9M
 
 
 
 
 
Funds From Operations-63.3M-71.7M-48.7M-44.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-111.0K-1.2M10.2M13.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-63.2M-70.6M-58.9M-58.4M
 
 
 
 
 
 
InvestingIncrease In Investments-90.5M-140.7M-109.3M-103.8M
 
 
 
 
 
Decrease In Investments159.9M194.2M147.8M123.2M
 
 
 
 
 
Capital Expenditures-249.0K-485.0K-264.0K-56.0K
 
 
 
 
 
Net Cash Flow Investing69.1M52.9M38.3M19.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale3.4M11.5M7.0M7.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing596.0K0.000.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing4.0M11.5M7.0M7.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash4.0K-1.0K-3.0K-1.0K
 
 
 
 
 
 
Net Change In Cash9.9M-6.1M-13.6M-31.2M